HapticV1, PascalFrancis, Corpus, bibRecord, 000A98

Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens

Identifieur interne : 000A98 ( PascalFrancis/Corpus ); précédent : 000A97; suivant : 000A99

Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens

Auteurs : Matthias G. Wirtitsch ; Rupert Menapace ; Michael Georgopoulos ; Georg Rainer ; Wolf Buehl ; Harald Heinzl

Source :

Journal of cataract and refractive surgery [ 0886-3350 ] ; 2007.

RBID : Pascal:07-0481994

Descripteurs français

Pascal (Inist)
- Tonus oculaire, Primaire, Postérieur, Continu, Capsulorhexis, Chirurgie, Dorzolamide, Antiglaucomateux, Timolol, Randomisation, Sécurité, Toxicité, Comparaison intraindividuelle, Lentille intraoculaire, Ophtalmologie, Traitement.

English descriptors

KwdEn :
- Antiglaucomatous agent, Capsulorhexis, Continuous, Dorzolamide, Intraindividual comparison, Intraocular lens, Intraocular pressure, Ophthalmology, Posterior, Primary, Randomization, Safety, Surgery, Timolol, Toxicity, Treatment.

Abstract

PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0886-3350`
A02	`01`			`@0 JCSUEV`
A03		`1`		`@0 J. cataract refractive surg.`
A05				`@2 33`
A06				`@2 10`
A08	`01`	`1`	`ENG`	`@1 Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens`
A11	`01`	`1`		`@1 WIRTITSCH (Matthias G.)`
A11	`02`	`1`		`@1 MENAPACE (Rupert)`
A11	`03`	`1`		`@1 GEORGOPOULOS (Michael)`
A11	`04`	`1`		`@1 RAINER (Georg)`
A11	`05`	`1`		`@1 BUEHL (Wolf)`
A11	`06`	`1`		`@1 HEINZL (Harald)`
A14	`01`			`@1 Department of Ophthalmology, Medical University of Vienna @3 AUT @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.`
A14	`02`			`@1 Department of Ophthalmology Hietzing Hospital @2 Vienna @3 AUT @Z 1 aut.`
A14	`03`			`@1 Core Unit for Medical Statistics and Informatics, Medical University of Vienna @3 AUT @Z 6 aut.`
A20				`@1 1754-1759`
A21				`@1 2007`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20937 @5 354000143465800210`
A44				`@0 0000 @1 © 2007 INIST-CNRS. All rights reserved.`
A45				`@0 32 ref.`
A47	`01`	`1`		`@0 07-0481994`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of cataract and refractive surgery`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.
C02	`01`	`X`		`@0 002B25B`
C03	`01`	`X`	`FRE`	`@0 Tonus oculaire @5 02`
C03	`01`	`X`	`ENG`	`@0 Intraocular pressure @5 02`
C03	`01`	`X`	`SPA`	`@0 Tono ocular @5 02`
C03	`02`	`X`	`FRE`	`@0 Primaire @5 03`
C03	`02`	`X`	`ENG`	`@0 Primary @5 03`
C03	`02`	`X`	`SPA`	`@0 Primario @5 03`
C03	`03`	`X`	`FRE`	`@0 Postérieur @5 05`
C03	`03`	`X`	`ENG`	`@0 Posterior @5 05`
C03	`03`	`X`	`SPA`	`@0 Posterior @5 05`
C03	`04`	`X`	`FRE`	`@0 Continu @5 06`
C03	`04`	`X`	`ENG`	`@0 Continuous @5 06`
C03	`04`	`X`	`SPA`	`@0 Contínuo @5 06`
C03	`05`	`X`	`FRE`	`@0 Capsulorhexis @5 08`
C03	`05`	`X`	`ENG`	`@0 Capsulorhexis @5 08`
C03	`05`	`X`	`SPA`	`@0 Capsulorexis @5 08`
C03	`06`	`X`	`FRE`	`@0 Chirurgie @5 09`
C03	`06`	`X`	`ENG`	`@0 Surgery @5 09`
C03	`06`	`X`	`SPA`	`@0 Cirugía @5 09`
C03	`07`	`X`	`FRE`	`@0 Dorzolamide @2 NK @2 FR @5 11`
C03	`07`	`X`	`ENG`	`@0 Dorzolamide @2 NK @2 FR @5 11`
C03	`07`	`X`	`SPA`	`@0 Dorzolamida @2 NK @2 FR @5 11`
C03	`08`	`X`	`FRE`	`@0 Antiglaucomateux @5 12`
C03	`08`	`X`	`ENG`	`@0 Antiglaucomatous agent @5 12`
C03	`08`	`X`	`SPA`	`@0 Antiglaucomatoso @5 12`
C03	`09`	`X`	`FRE`	`@0 Timolol @2 NK @2 FR @5 14`
C03	`09`	`X`	`ENG`	`@0 Timolol @2 NK @2 FR @5 14`
C03	`09`	`X`	`SPA`	`@0 Timolol @2 NK @2 FR @5 14`
C03	`10`	`X`	`FRE`	`@0 Randomisation @5 15`
C03	`10`	`X`	`ENG`	`@0 Randomization @5 15`
C03	`10`	`X`	`SPA`	`@0 Aleatorización @5 15`
C03	`11`	`X`	`FRE`	`@0 Sécurité @5 17`
C03	`11`	`X`	`ENG`	`@0 Safety @5 17`
C03	`11`	`X`	`SPA`	`@0 Seguridad @5 17`
C03	`12`	`X`	`FRE`	`@0 Toxicité @5 18`
C03	`12`	`X`	`ENG`	`@0 Toxicity @5 18`
C03	`12`	`X`	`SPA`	`@0 Toxicidad @5 18`
C03	`13`	`X`	`FRE`	`@0 Comparaison intraindividuelle @5 19`
C03	`13`	`X`	`ENG`	`@0 Intraindividual comparison @5 19`
C03	`13`	`X`	`SPA`	`@0 Comparación intraindividual @5 19`
C03	`14`	`X`	`FRE`	`@0 Lentille intraoculaire @5 20`
C03	`14`	`X`	`ENG`	`@0 Intraocular lens @5 20`
C03	`14`	`X`	`SPA`	`@0 Lente intraocular @5 20`
C03	`15`	`X`	`FRE`	`@0 Ophtalmologie @5 21`
C03	`15`	`X`	`ENG`	`@0 Ophthalmology @5 21`
C03	`15`	`X`	`SPA`	`@0 Oftalmología @5 21`
C03	`16`	`X`	`FRE`	`@0 Traitement @5 25`
C03	`16`	`X`	`ENG`	`@0 Treatment @5 25`
C03	`16`	`X`	`SPA`	`@0 Tratamiento @5 25`
C07	`01`	`X`	`FRE`	`@0 Carbonate dehydratase @2 FE @5 37`
C07	`01`	`X`	`ENG`	`@0 Carbonate dehydratase @2 FE @5 37`
C07	`01`	`X`	`SPA`	`@0 Carbonate dehydratase @2 FE @5 37`
C07	`02`	`X`	`FRE`	`@0 Hydro-lyases @2 FE`
C07	`02`	`X`	`ENG`	`@0 Hydro-lyases @2 FE`
C07	`02`	`X`	`SPA`	`@0 Hydro-lyases @2 FE`
C07	`03`	`X`	`FRE`	`@0 Carbon-oxygen lyases @2 FE`
C07	`03`	`X`	`ENG`	`@0 Carbon-oxygen lyases @2 FE`
C07	`03`	`X`	`SPA`	`@0 Carbon-oxygen lyases @2 FE`
C07	`04`	`X`	`FRE`	`@0 Lyases @2 FE`
C07	`04`	`X`	`ENG`	`@0 Lyases @2 FE`
C07	`04`	`X`	`SPA`	`@0 Lyases @2 FE`
C07	`05`	`X`	`FRE`	`@0 Enzyme @2 FE`
C07	`05`	`X`	`ENG`	`@0 Enzyme @2 FE`
C07	`05`	`X`	`SPA`	`@0 Enzima @2 FE`
C07	`06`	`X`	`FRE`	`@0 Inhibiteur enzyme @5 38`
C07	`06`	`X`	`ENG`	`@0 Enzyme inhibitor @5 38`
C07	`06`	`X`	`SPA`	`@0 Inhibidor enzima @5 38`
C07	`07`	`X`	`FRE`	`@0 Sulfamides @5 39`
C07	`07`	`X`	`ENG`	`@0 Sulfanilamide derivatives @5 39`
C07	`07`	`X`	`SPA`	`@0 Sulfamidas @5 39`
C07	`08`	`X`	`FRE`	`@0 Antagoniste @5 40`
C07	`08`	`X`	`ENG`	`@0 Antagonist @5 40`
C07	`08`	`X`	`SPA`	`@0 Antagonista @5 40`
C07	`09`	`X`	`FRE`	`@0 Bloquant β-adrénergique @5 41`
C07	`09`	`X`	`ENG`	`@0 Beta blocking agent @5 41`
C07	`09`	`X`	`SPA`	`@0 Bloqueador β-adrenérgico @5 41`
C07	`10`	`X`	`FRE`	`@0 Récepteur β-adrénergique @5 42`
C07	`10`	`X`	`ENG`	`@0 β-Adrenergic receptor @5 42 @6 «β-»Adrenergic receptor`
C07	`10`	`X`	`SPA`	`@0 Receptor β-adrenérgico @5 42`
N21				`@1 316`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 07-0481994 INIST
ET :	Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens
AU :	WIRTITSCH (Matthias G.); MENAPACE (Rupert); GEORGOPOULOS (Michael); RAINER (Georg); BUEHL (Wolf); HEINZL (Harald)
AF :	Department of Ophthalmology, Medical University of Vienna/Autriche (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Department of Ophthalmology Hietzing Hospital/Vienna/Autriche (1 aut.); Core Unit for Medical Statistics and Informatics, Medical University of Vienna/Autriche (6 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 2007; Vol. 33; No. 10; Pp. 1754-1759; Bibl. 32 ref.
LA :	Anglais
EA :	PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.
CC :	002B25B
FD :	Tonus oculaire; Primaire; Postérieur; Continu; Capsulorhexis; Chirurgie; Dorzolamide; Antiglaucomateux; Timolol; Randomisation; Sécurité; Toxicité; Comparaison intraindividuelle; Lentille intraoculaire; Ophtalmologie; Traitement
FG :	Carbonate dehydratase; Hydro-lyases; Carbon-oxygen lyases; Lyases; Enzyme; Inhibiteur enzyme; Sulfamides; Antagoniste; Bloquant β-adrénergique; Récepteur β-adrénergique
ED :	Intraocular pressure; Primary; Posterior; Continuous; Capsulorhexis; Surgery; Dorzolamide; Antiglaucomatous agent; Timolol; Randomization; Safety; Toxicity; Intraindividual comparison; Intraocular lens; Ophthalmology; Treatment
EG :	Carbonate dehydratase; Hydro-lyases; Carbon-oxygen lyases; Lyases; Enzyme; Enzyme inhibitor; Sulfanilamide derivatives; Antagonist; Beta blocking agent; β-Adrenergic receptor
SD :	Tono ocular; Primario; Posterior; Contínuo; Capsulorexis; Cirugía; Dorzolamida; Antiglaucomatoso; Timolol; Aleatorización; Seguridad; Toxicidad; Comparación intraindividual; Lente intraocular; Oftalmología; Tratamiento
LO :	INIST-20937.354000143465800210
ID :	07-0481994

Links to Exploration step

Pascal:07-0481994

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens</title>
<author><name sortKey="Wirtitsch, Matthias G" sort="Wirtitsch, Matthias G" uniqKey="Wirtitsch M" first="Matthias G." last="Wirtitsch">Matthias G. Wirtitsch</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Ophthalmology Hietzing Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Menapace, Rupert" sort="Menapace, Rupert" uniqKey="Menapace R" first="Rupert" last="Menapace">Rupert Menapace</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Georgopoulos, Michael" sort="Georgopoulos, Michael" uniqKey="Georgopoulos M" first="Michael" last="Georgopoulos">Michael Georgopoulos</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rainer, Georg" sort="Rainer, Georg" uniqKey="Rainer G" first="Georg" last="Rainer">Georg Rainer</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Buehl, Wolf" sort="Buehl, Wolf" uniqKey="Buehl W" first="Wolf" last="Buehl">Wolf Buehl</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Heinzl, Harald" sort="Heinzl, Harald" uniqKey="Heinzl H" first="Harald" last="Heinzl">Harald Heinzl</name>
<affiliation><inist:fA14 i1="03"><s1>Core Unit for Medical Statistics and Informatics, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0481994</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0481994 INIST</idno>
<idno type="RBID">Pascal:07-0481994</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens</title>
<author><name sortKey="Wirtitsch, Matthias G" sort="Wirtitsch, Matthias G" uniqKey="Wirtitsch M" first="Matthias G." last="Wirtitsch">Matthias G. Wirtitsch</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>Department of Ophthalmology Hietzing Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Menapace, Rupert" sort="Menapace, Rupert" uniqKey="Menapace R" first="Rupert" last="Menapace">Rupert Menapace</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Georgopoulos, Michael" sort="Georgopoulos, Michael" uniqKey="Georgopoulos M" first="Michael" last="Georgopoulos">Michael Georgopoulos</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rainer, Georg" sort="Rainer, Georg" uniqKey="Rainer G" first="Georg" last="Rainer">Georg Rainer</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Buehl, Wolf" sort="Buehl, Wolf" uniqKey="Buehl W" first="Wolf" last="Buehl">Wolf Buehl</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Heinzl, Harald" sort="Heinzl, Harald" uniqKey="Heinzl H" first="Harald" last="Heinzl">Harald Heinzl</name>
<affiliation><inist:fA14 i1="03"><s1>Core Unit for Medical Statistics and Informatics, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiglaucomatous agent</term>
<term>Capsulorhexis</term>
<term>Continuous</term>
<term>Dorzolamide</term>
<term>Intraindividual comparison</term>
<term>Intraocular lens</term>
<term>Intraocular pressure</term>
<term>Ophthalmology</term>
<term>Posterior</term>
<term>Primary</term>
<term>Randomization</term>
<term>Safety</term>
<term>Surgery</term>
<term>Timolol</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Tonus oculaire</term>
<term>Primaire</term>
<term>Postérieur</term>
<term>Continu</term>
<term>Capsulorhexis</term>
<term>Chirurgie</term>
<term>Dorzolamide</term>
<term>Antiglaucomateux</term>
<term>Timolol</term>
<term>Randomisation</term>
<term>Sécurité</term>
<term>Toxicité</term>
<term>Comparaison intraindividuelle</term>
<term>Lentille intraoculaire</term>
<term>Ophtalmologie</term>
<term>Traitement</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0886-3350</s0>
</fA01>
<fA02 i1="01"><s0>JCSUEV</s0>
</fA02>
<fA03 i2="1"><s0>J. cataract refractive surg.</s0>
</fA03>
<fA05><s2>33</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WIRTITSCH (Matthias G.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>MENAPACE (Rupert)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GEORGOPOULOS (Michael)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>RAINER (Georg)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BUEHL (Wolf)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>HEINZL (Harald)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Ophthalmology, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Ophthalmology Hietzing Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Core Unit for Medical Statistics and Informatics, Medical University of Vienna</s1>
<s3>AUT</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>1754-1759</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20937</s2>
<s5>354000143465800210</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0481994</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of cataract and refractive surgery</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B25B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Tonus oculaire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Intraocular pressure</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Tono ocular</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Primaire</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Primary</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Primario</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Postérieur</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Posterior</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Posterior</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Continu</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Continuous</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Contínuo</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Capsulorhexis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Capsulorhexis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Capsulorexis</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Chirurgie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Surgery</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Cirugía</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Dorzolamide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Dorzolamide</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Dorzolamida</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Antiglaucomateux</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Antiglaucomatous agent</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Antiglaucomatoso</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Timolol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Timolol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Timolol</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Randomisation</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Randomization</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Aleatorización</s0>
<s5>15</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Sécurité</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Safety</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Seguridad</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Toxicité</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Toxicity</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Toxicidad</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Comparaison intraindividuelle</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Intraindividual comparison</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Comparación intraindividual</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Lentille intraoculaire</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Intraocular lens</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Lente intraocular</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Ophtalmologie</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Ophthalmology</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Oftalmología</s0>
<s5>21</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE"><s0>Traitement</s0>
<s5>25</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG"><s0>Treatment</s0>
<s5>25</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>25</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Carbonate dehydratase</s0>
<s2>FE</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Carbonate dehydratase</s0>
<s2>FE</s2>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Carbonate dehydratase</s0>
<s2>FE</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Hydro-lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Hydro-lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Hydro-lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Carbon-oxygen lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Carbon-oxygen lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Carbon-oxygen lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Lyases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Inhibiteur enzyme</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Enzyme inhibitor</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Inhibidor enzima</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Sulfamides</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Sulfanilamide derivatives</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Sulfamidas</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Antagoniste</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Antagonist</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Antagonista</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Bloquant β-adrénergique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Beta blocking agent</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Bloqueador β-adrenérgico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Récepteur β-adrénergique</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>β-Adrenergic receptor</s0>
<s5>42</s5>
<s6>«β-»Adrenergic receptor</s6>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Receptor β-adrenérgico</s0>
<s5>42</s5>
</fC07>
<fN21><s1>316</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 07-0481994 INIST</NO>
<ET>Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens</ET>
<AU>WIRTITSCH (Matthias G.); MENAPACE (Rupert); GEORGOPOULOS (Michael); RAINER (Georg); BUEHL (Wolf); HEINZL (Harald)</AU>
<AF>Department of Ophthalmology, Medical University of Vienna/Autriche (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Department of Ophthalmology Hietzing Hospital/Vienna/Autriche (1 aut.); Core Unit for Medical Statistics and Informatics, Medical University of Vienna/Autriche (6 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of cataract and refractive surgery; ISSN 0886-3350; Coden JCSUEV; Etats-Unis; Da. 2007; Vol. 33; No. 10; Pp. 1754-1759; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. SETTING: Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. METHODS: In this prospective randomized double-masked bilateral study, 88 eyes of 44 consecutive patients with age-related cataract were included in an intraindividual comparison study. All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. Patients were randomly assigned to receive an ACR6D SE IOL (Laboratoires Cornéal) in 1 eye and a Centerflex (C-flex) 570C IOL (Rayner Surgical GmbH) in the contralateral eye. The IOP was measured at baseline and postoperatively at 6 and 24 hours as well as 1 week. RESULTS: Intraindividual comparison showed statistically significantly higher IOP measurements in the C-flex 570C nonangulated IOL group than in the ACR6D SE angulated IOL group at 24 hours (P = .003) and 1 week (P = .043). The highest IOP spikes (34 mm Hg) were at 6 hours in 2 eyes with a C-flex 570C IOL. The ACR6D SE group had statistically significant changes in IOP between preoperative and all postoperative time points. In the C-flex 570C group, the only statistically significant change in IOP was between preoperatively and 6 hours postoperatively. CONCLUSIONS: Cataract surgery with PPCCC was safe in terms of the postoperative IOP course. Haptic angulation slightly decreased the overall IOP rise and the incidence of IOP rises above 30 mm Hg.</EA>
<CC>002B25B</CC>
<FD>Tonus oculaire; Primaire; Postérieur; Continu; Capsulorhexis; Chirurgie; Dorzolamide; Antiglaucomateux; Timolol; Randomisation; Sécurité; Toxicité; Comparaison intraindividuelle; Lentille intraoculaire; Ophtalmologie; Traitement</FD>
<FG>Carbonate dehydratase; Hydro-lyases; Carbon-oxygen lyases; Lyases; Enzyme; Inhibiteur enzyme; Sulfamides; Antagoniste; Bloquant β-adrénergique; Récepteur β-adrénergique</FG>
<ED>Intraocular pressure; Primary; Posterior; Continuous; Capsulorhexis; Surgery; Dorzolamide; Antiglaucomatous agent; Timolol; Randomization; Safety; Toxicity; Intraindividual comparison; Intraocular lens; Ophthalmology; Treatment</ED>
<EG>Carbonate dehydratase; Hydro-lyases; Carbon-oxygen lyases; Lyases; Enzyme; Enzyme inhibitor; Sulfanilamide derivatives; Antagonist; Beta blocking agent; β-Adrenergic receptor</EG>
<SD>Tono ocular; Primario; Posterior; Contínuo; Capsulorexis; Cirugía; Dorzolamida; Antiglaucomatoso; Timolol; Aleatorización; Seguridad; Toxicidad; Comparación intraindividual; Lente intraocular; Oftalmología; Tratamiento</SD>
<LO>INIST-20937.354000143465800210</LO>
<ID>07-0481994</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A98 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A98 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Ticri/CIDE
   |area=    HapticV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0481994
   |texte=   Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens
}}

This area was generated with Dilib version V0.6.23.
Data generation: Mon Jun 13 01:09:46 2016. Site generation: Wed Mar 6 09:54:07 2024

	Serveur d'exploration sur les dispositifs haptiques
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les dispositifs haptiques

Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens

Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination : Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri